Telemedicine has moved quickly in the UK. Advertising rules have moved with it and regulators are now considerably better equipped to find campaigns that cross the line.
For telemedicine businesses, compliance needs to cover more than the advert itself. The wording of a social post, the treatment described on a landing page, the way a clinician is presented, an influencer partnership and what happens after somebody clicks can all matter.
The ASA has also increased its use of technology to monitor advertising at scale. Its Active Ad Monitoring system uses machine learning to identify advertising that may require investigation. The ASA has been particularly active around health, weight loss treatments and prescription only medicines.
For marketing teams, the practical question is simple: where can a normal piece of digital marketing turn into a compliance problem?
What regulators are looking at
The ASA, MHRA and professional regulators each have different responsibilities but their rules overlap across many telemedicine customer journeys.
Prescription only medicines are a particularly important area. Advertising named prescription only medicines to the public is prohibited. This includes advertising through websites, paid search, social media and influencers.
The ASA has also made clear that its monitoring is increasingly proactive. In its reporting, a large proportion of advertising amended or withdrawn following ASA intervention originated from proactive monitoring rather than consumer complaints.
Waiting for somebody to complain is therefore a poor compliance strategy.
10 common telemedicine advertising scenarios
1. Facebook advertising that mentions a medicine or treatment brand
The first question is what the name actually represents. Advertising a telemedicine service is different from advertising a named prescription only medicine.
If the wording promotes a prescription only medicine to the public, the campaign can breach medicines advertising rules even when the overall service itself can legitimately be marketed.
2. Influencer posts marked as affiliate content
Commercial relationships need to be obvious to the person seeing the content. An affiliate reference buried in a caption may not make the advertising nature of the post sufficiently clear.
Health advertising creates an additional complication because the content itself also needs to comply with the rules governing medicinal and health claims.
3. Google Ads promoting unlicensed medicines
Medicines advertising has specific licensing requirements. A telemedicine platform does not create an exemption simply because consultation, prescribing or fulfilment happens online.
The medicine, territory, claim and audience all need to be considered before advertising goes live.
4. LinkedIn advertising using tracking technology
Advertising pixels and measurement technology can be used but the data protection position needs to be considered properly.
Telemedicine businesses can handle information relating to health, which creates a much higher level of sensitivity than ordinary marketing data. Privacy information, consent where required, data flows and the information sent to advertising platforms all need scrutiny.
5. TikTok videos built around patient testimonials
Testimonials can be useful but they do not give advertisers permission to make claims that could not otherwise be made.
A patient talking informally about a result can still create a medicinal or health claim. Prescription only medicine restrictions also continue to apply regardless of whether the content looks like conventional advertising.
6. Landing pages promoting a named prescription only medicine
This is an area where the advert and landing page need to be considered together.
An advert may avoid naming a prescription only medicine but the customer journey can still become problematic if the next page immediately turns into direct product promotion.
Telemedicine marketing therefore needs to be reviewed as a journey rather than as a collection of isolated assets.
7. Health advertising appearing around content for children
Placement matters as well as copy. Advertising health related products or services around content primarily intended for children can create additional regulatory concerns.
Audience settings should therefore form part of the compliance review rather than being treated purely as a media buying decision.
8. Organic social media discussing treatment benefits
Calling something an organic post does not automatically remove regulatory risk.
Content published by a business can still amount to marketing communication depending on its purpose and presentation. Posts concerning medicines and treatment outcomes therefore need the same careful review as paid content.
9. Educational video advertising without a medicine or treatment claim
Condition awareness and educational content can provide telemedicine businesses with useful ways to communicate without directly promoting a particular prescription only medicine.
The distinction depends on what the content actually says, where it leads and whether the overall communication promotes a particular product.
10. Educational articles about a health condition
Useful condition information can play an important role in telemedicine marketing.
Articles explaining symptoms, treatment routes, consultation processes and when somebody should seek professional advice can help people make better decisions while also creating useful search content.
The commercial purpose needs to remain compatible with the regulatory position. An educational article should not simply become disguised prescription medicine advertising.
Prescription only medicines remain the key dividing line
One of the most important distinctions in UK telemedicine advertising is between marketing a healthcare service and advertising a prescription only medicine.
Prescription only medicines cannot be advertised to the public.
Telemedicine businesses can still provide factual information about medicines in appropriate contexts. The presentation matters. Information should remain factual and balanced and should not simply operate as an inducement to purchase a particular prescription medicine.
This becomes especially important in areas such as weight management where the medicine itself may be the thing consumers recognise and search for.
Clinician credentials need to be presented accurately
Telemedicine marketing frequently relies on clinician authority. Qualifications, professional status and registration therefore need to be described accurately.
Marketing teams should check professional registers and make sure titles, qualifications and specialist claims accurately reflect the person being presented.
General Medical Council and General Dental Council information can be used when checking relevant professional registrations.
UK rules still matter when the business is based elsewhere
Telemedicine businesses often operate across borders. Marketing may be managed in one country, technology may sit in another and the patient may be in the UK.
If advertising is directed at UK consumers, UK advertising and medicines rules need to be considered as part of the campaign.
International marketing teams should therefore avoid assuming that material approved for another market can simply be reused in Britain.
Some telemedicine software may also be a medical device
Telemedicine platforms increasingly include symptom assessment, diagnostic support, monitoring and clinical decision tools.
Depending on the intended purpose and functionality, software can fall within medical device regulation.
The MHRA provides guidance on medical devices and UK regulatory requirements. Product and marketing teams should establish the regulatory status of the technology before making claims about what it does.
Advertising rules changed again in 2025
Changes connected with the Digital Markets, Competition and Consumers Act strengthened the wider consumer protection framework.
For healthcare marketers, familiar principles remain central:
- Claims need appropriate evidence
- Material information should be clear
- Advertising should not mislead consumers
- Commercial practices should not exploit vulnerable people
- Marketing needs to reflect the actual service being offered
These principles matter particularly in healthcare because people may be making decisions while concerned about their health, appearance, weight or access to treatment.
Advertising compliance and data protection increasingly overlap
Telemedicine businesses also operate within the requirements of UK GDPR and the Data Protection Act 2018.
Marketing teams should understand what information is being collected at each stage of the journey and where it goes.
Areas to review include:
- The lawful basis for processing personal information
- The treatment of health related data
- Cookie and advertising technology
- Information passed to advertising platforms
- Data minimisation
- Privacy information
- Security and access controls
- Processes for dealing with data incidents
A compliant advert can still create a problem if the data collected behind it is being handled incorrectly.
How WLW FUTURE approaches telemedicine marketing
For WLW FUTURE, compliance sits inside the marketing and customer journey rather than being something added to an advert at the end.
We look at how the proposition moves from media into the website and from the website into enquiry, consultation and follow up.
Advertising and landing pages
We review the connection between adverts, claims, treatment descriptions, calls to action and the pages people reach after clicking.
Content and search
Condition information, treatment education and useful patient content can create valuable search visibility without every piece of content becoming product promotion.
Customer journey
Compliance can change as somebody moves through the journey. An advert may be acceptable while wording deeper inside the website creates the problem.
Reviewing the whole route makes those inconsistencies easier to find.
Claims and evidence
Strong healthcare marketing still needs evidence. We help clients identify which claims are commercially useful, what evidence supports them and where wording needs to be more precise.
Ongoing review
Platforms, campaigns and guidance change. Compliance therefore needs to form part of ongoing marketing management rather than a single launch exercise.
A practical telemedicine advertising review
Before launch
- Review adverts and landing pages together
- Check for public promotion of prescription only medicines
- Verify clinician titles, credentials and registrations
- Check treatment and outcome claims against available evidence
- Confirm whether relevant software could fall within medical device regulation
- Review advertising tracking and data collection
Review the content
- Separate useful health education from direct medicine promotion
- Check testimonials and patient stories
- Review influencer and affiliate disclosure
- Check pricing and promotional claims
- Review treatment comparison content
- Check the complete route from advert to conversion
Keep monitoring
- Review active advertising regularly
- Track relevant ASA rulings
- Watch changes to MHRA and CAP guidance
- Review new landing pages before campaigns point traffic at them
- Check changes introduced by media, product and development teams
What happens when advertising goes wrong?
For most businesses, the immediate problem is losing the campaign. For a healthcare business, the consequences can spread further.
Depending on the circumstances, a compliance problem can lead to:
- Advertising being amended or removed
- Publication of an adverse ASA ruling
- Referral to another regulator
- MHRA scrutiny
- Data protection investigation
- Professional complaints
- Loss of advertising platform access
- Reputational damage
The commercial cost can therefore be considerably greater than the value of the individual advert that caused the problem.
Useful UK regulatory resources
- CAP Code section 12: Medicines, medical devices, health related products and beauty products
- MHRA guidance on advertising medicines
- MHRA guidance on medical device regulation
- General Medical Council
- Information Commissioner’s Office guidance
Build compliance into the campaign before it goes live
Telemedicine is a strong growth market but it operates inside one of the most closely regulated areas of advertising.
The businesses best placed to grow are likely to be those which can make persuasive claims without overclaiming, explain treatments without improperly promoting medicines and collect useful marketing data without compromising patient privacy.
Good compliance should support good marketing. Clear information, credible evidence and a well designed customer journey reduce risk while also helping patients make more confident decisions.
If you are planning a telemedicine campaign or want an existing customer journey reviewed, talk to WLW FUTURE about advertising, content, landing pages and compliance across the complete journey.
